Document is current
Any future updates will be listed below
-
Authors
Zhu, Mengou
Pickens, Chiagozie I.
Markov, Nikolay S.
Pawlowski, Anna
Kang, Mengjia
Rasmussen, Luke V.
Walter, James M.
Nadig, Nandita R.
Singer, Benjamin D.
Wunderink, Richard G.
Gao, Catherine A.
,
-
Funding
Funding for this research was provided by:
NIH/NIAID (U19AI135964, U19AI135964, U19AI135964)
Northwestern University Clinical and Translational Sciences Institute (5KL2TR001424-09)
NIH (R01HL149883, R01HL149883)
NIH/NHLBI (K23HL169815)
Parker B. Francis Opportunity Award
ATS unrestricted grant
- License Information
-
More Information
Article History
Received: 28 November 2024
Accepted: 21 April 2025
First Online: 3 May 2025
Declarations
:
: This study was approved by the Northwestern University Institutional Review Board with study ID STU00204868.
: Informed consent was acquired from all study participants or their surrogates.
: B.D.S. holds US patent 10,905,706, “Compositions and methods to accelerate resolution of acute lung inflammation,” and serves on the scientific advisory board of Zoe Biosciences, in which he holds stock options. Other authors declare no conflicts of interest.
